S&P 500 Futures
(0.62%) 5 077.75 points
Dow Jones Futures
(0.44%) 38 236 points
Nasdaq Futures
(0.76%) 17 571 points
Oil
(0.96%) $79.76
Gas
(1.92%) $1.969
Gold
(-0.14%) $2 307.80
Silver
(-1.04%) $26.47
Platinum
(0.73%) $961.90
USD/EUR
(0.16%) $0.934
USD/NOK
(0.29%) $11.06
USD/GBP
(0.10%) $0.799
USD/RUB
(-1.40%) $91.96

Realaus laiko atnaujinimai Zynex Inc [ZYXI]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Medical Distribution
BUY
50.00%
return 1.64%
SELL
100.00%
return -0.08%
Atnaujinta1 geg. 2024 @ 23:00

7.29% $ 11.77

PARDAVIMAS 112184 min ago

@ $12.36

Išleistas: 14 vas. 2024 @ 16:30


Grąža: -4.77%


Ankstesnis signalas: vas. 12 - 22:00


Ankstesnis signalas: Pirkimas


Grąža: -1.98 %

Live Chart Being Loaded With Signals

Commentary (1 geg. 2024 @ 23:00):
Profile picture for Zynex Inc

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation...

Stats
Šios dienos apimtis 269 443
Vidutinė apimtis 192 104
Rinkos kapitalizacija 378.64M
EPS $0 ( 2024-04-25 )
Kita pelno data ( $0.0300 ) 2024-05-16
Last Dividend $0.100 ( 2022-01-05 )
Next Dividend $0 ( N/A )
P/E 43.59
ATR14 $0.0260 (0.22%)
Insider Trading
Date Person Action Amount type
2024-04-30 Lucsok Anna Buy 1 025 Common Stock (Restricted Stock Award)
2024-04-27 Lucsok Anna Buy 5 000 Common Stock (Restricted Stock Award)
2024-04-29 Lucsok Anna Sell 2 395 Common Stock
2024-03-25 Moorhead Daniel J Sell 6 084 Common Stock
2024-03-25 Lucsok Anna Sell 7 672 Common Stock
INSIDER POWER
-36.67
Last 100 transactions
Buy: 371 745 | Sell: 901 167

Tūris Koreliacija

Ilgas: 0.19 (neutral)
Trumpas: 0.63 (weak)
Signal:(41.941) Neutral

Zynex Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
MMAC0.896
BOCH0.863
BMRN0.848
CTRN0.841
STRO0.838
XEL0.832
CAAS0.826
ISRG0.821
AMRB0.814
GLSI0.812
10 Labiausiai neigiamai susiję koreliacijos
APOP-0.971
RMRM-0.939
MAGS-0.936
TDAC-0.897
CMLF-0.868
SVOK-0.836
EMBCV-0.824
TLGT-0.823
SPRT-0.82
TALS-0.82

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Zynex Inc Koreliacija - Valiuta/Žaliavos

The country flag 0.23
( neutral )
The country flag 0.31
( neutral )
The country flag 0.00
( neutral )
The country flag -0.48
( neutral )
The country flag 0.49
( neutral )
The country flag 0.50
( neutral )

Zynex Inc Finansinės ataskaitos

Annual 2023
Pajamos: $184.32M
Bruto pelnas: $145.96M (79.19 %)
EPS: $0.270
FY 2023
Pajamos: $184.32M
Bruto pelnas: $145.96M (79.19 %)
EPS: $0.270
FY 2022
Pajamos: $158.17M
Bruto pelnas: $126.16M (79.77 %)
EPS: $0.440
FY 2021
Pajamos: $130.30M
Bruto pelnas: $102.98M (79.03 %)
EPS: $0.450

Financial Reports:

No articles found.

Zynex Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Zynex Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 9.15 - good (91.49%) | Divividend Growth Potential Score: 5.53 - Potential for dividend initiation, but uncertain (10.55%)
Information
First Dividend $0.136 2014-06-17
Last Dividend $0.100 2022-01-05
Next Dividend $0 N/A
Payout Date 2022-01-21
Next Payout Date N/A
# dividends 3 --
Total Paid Out $0.300 --
Avg. Dividend % Per Year 0.21% --
Score 2.52 --
Div. Sustainability Score 9.15
Div.Growth Potential Score 5.53
Div. Directional Score 7.34 --
Next Divdend (Est)
(2026-01-09)
$0 Estimate 0.00 %
Dividend Stability
0.02 Very Bad
Dividend Score
2.52
Pay Frequency
Sporadic
Yearly Payout
Year Amount Yield
2014 $0.136 42.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0.0636 2.14%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0.100 1.07%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.04331.5009.1310.00[0 - 0.5]
returnOnAssetsTTM0.06471.2007.849.41[0 - 0.3]
returnOnEquityTTM0.1631.5009.3010.00[0.1 - 1]
payoutRatioTTM0.000367-1.00010.00-10.00[0 - 1]
currentRatioTTM3.580.80010.008.00[1 - 3]
quickRatioTTM2.680.80010.008.00[0.8 - 2.5]
cashRatioTTM1.5111.5002.724.08[0.2 - 2]
debtRatioTTM0.598-1.5000.0397-0.0596[0 - 0.6]
interestCoverageTTM22.131.0002.912.91[3 - 30]
operatingCashFlowPerShareTTM0.5552.009.8110.00[0 - 30]
freeCashFlowPerShareTTM0.5192.009.7410.00[0 - 20]
debtEquityRatioTTM2.28-1.5000.884-1.326[0 - 2.5]
grossProfitMarginTTM0.7971.0000.05810.0581[0.2 - 0.8]
operatingProfitMarginTTM0.05841.000-0.832-0.832[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2381.0009.799.79[0.2 - 2]
assetTurnoverTTM1.4950.8003.372.69[0.5 - 2]
Total Score9.15

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM46.581.0005.400[1 - 100]
returnOnEquityTTM0.1632.509.5510.00[0.1 - 1.5]
freeCashFlowPerShareTTM0.5192.009.8310.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.5552.009.8110.00[0 - 30]
payoutRatioTTM0.0003671.50010.00-10.00[0 - 1]
pegRatioTTM0.8791.5007.470[0.5 - 2]
operatingCashFlowSalesRatioTTM0.09521.000-0.1200[0.1 - 0.5]
Total Score5.53

Zynex Inc

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.